Friday, January 2, 2009


Monday, October 20, 2008

Sunday, October 19, 2008

THE SO-CALLED LEGAL MEANINGS OF NATURAL PERSON, ARTIFICIAL PERSON AND SOVEREIGN PERSON

In jurisprudence, a natural person is a human being perceptible through the senses and subject to physical laws, as opposed to an artificial, legal or juristic person, i.e., an organization that the law treats for some purposes as if it were a person distinct from its members or owner.

A legal person, also called juridical person or juristic person,[1] is a legal entity through which the law allows a group of natural persons to act as if they were a single composite individual for certain purposes, or in some jurisdictions, for a single person to have a separate legal personality other than their own.[2][3] This legal fiction does not mean these entities are human beings, but rather means that the law allows them to act as persons for certain limited purposes—most commonly lawsuits, property ownership, and contracts. This concept is separate from and should not be confused with limited liability or the joint stock principle.[4] Also note that basic rights (like the rights to free speech and due process of law) do not necessarily follow from legal personhood. A legal person is sometimes called an artificial person or legal entity (although the latter is sometimes understood to include natural persons as well). Although the concept of a legal person is more central to Western law in both common law and civil law countries, it is also found in virtually every legal system.

Self-ownership (or sovereignty of the individual, individual sovereignty or individual autonomy) is the moral or natural right (aka Freedom) of a person to be the exclusive controller of his or her own body and life. It is the concept of property in one's own person. According to G. Cohen, the concept of self-ownership "says that each person enjoys, over herself and her powers, full and exclusive rights of control and use, and therefore owes no service or product to anyone else that she has not contracted to supply."

U DO THE KNOWLEDGE, GET THE WISDOM AND DRAW UP YOUR OWN UNDERSTANDING...The AntiTerrorist on the Freeman\Strawman\Man Pt1.mov

Saturday, October 18, 2008

THE REAL DRUG CARTELS












Oxycodone was first synthesized in a German laboratory in 1916, a few years after the German pharmaceutical company Bayer had stopped the mass production of heroin due to addiction and abuse by both patients and physicians. It was hoped that a thebaine-derived drug would retain the analgesic effects of morphine and heroin with less of the euphoric effect which led to addiction and over use. The subjective experience of a "high" was still reported for oxycodone, however, and it made its way into medical usage in small increments in most Western countries until the introduction of high strength preparations with inert (inactive) binders radically boosted oxycodone use. It was first introduced to the US market in May 1939 and is the active ingredient in a number of pain medications commonly prescribed for the relief of moderate to heavy pain, either with inert binders (oxycodone, OxyContin) or supplemental analgesics such as acetaminophen (Percocet, Endocet, Tylox, Roxicet) and aspirin (Percodan, Endodan, Roxiprin ). It is also sold in a sustained-release form by Mundipharma in Germany (Oxygesic), and in the United States by Purdue Pharma under the trade name OxyContin (Oxycodone Continuous release) as well as generic equivalents, and instant-release forms Endone, OxyIR, OxyNorm, Percolone, OxyFAST, Supeudol, and Roxicodone. More recently, ibuprofen has been added to oxycodone (Combunox).
Purdue was founded by Dr. John Purdue Gray and George Frederick Bingham in 1892 in New York City. It came under new private ownership in 1952. It currently employs about 1,200 people. The company's different branches include Purdue Pharma L.P., The Purdue Frederick Company, Purdue Pharmaceutical Products L.P., and Purdue Products L.P. (www.pharma.com).
The company's manufacturing takes place at three different sites, which include: Purdue Pharmaceuticals L.P., a plant located in Wilson, North Carolina; The P.F. Laboratories Inc. in Totowa, New Jersey; and Rhodes Technologies L.P. in Coventry, Rhode Island. Purdue Pharma L.P. also has research labs located in Cranbury, New Jersey. OxyContin is currently legally and illegally distributed throughout the U.S., Canada, and Mexico. Legal distribution takes place from the P.F. Laboratories Inc. in
Totowa, New Jersey. An extended-release formulation of oxycodone, OxyContin, was first introduced to the US market by Purdue in 1996. Purdue has multiple patents for OxyContin.
In July 2007, Purdue Frederick Company, a shell company of Purdue Pharma, was criminally convicted in US Federal Court in Virginia with misleading patients and physicians as to the addictive and abusive capabilities of OxyContin. They and their three CEO's Michael Friedman, Howard Udell and Paul Goldenheim pled guilty and were sentenced. The 3 convicted felons were sentenced to 400 hours of community service at a drug rehab facility and were put on probation.
Editors note: community service and probation????????? when black and latino youth are constantly being hauled away into federal and state prisons for decades for less than 100 grams of crack cocaine????? Their actions have resulted in scores of deaths and addictions in every state in the country. Marianne Skolek, Activist for Victims of OxyContin and Purdue Pharma continues in her efforts to further expose them for their criminal activities. Skolek recently filed a complaint with the FDA and Attorney Generals throughout the country against Purdue Pharma for their marketing to pregnant women for pain in pregnancy. In addition, Skolek has charged them with a violation of their probation for this marketing ploy which will result in scores of addictions and deaths of mothers and newborns.
Covidien Ltd. of Mansfield said today that one of its subsidiaries has reached an agreement with Purdue Pharma LP to end a patent infringement lawsuit between them. Covidien is a global provider of healthcare products and the subsidiary involved in the agreement is Mallinckrodt Inc. Headquartered in Stamford, Conn. Under the agreement between the two companies, Purdue will grant Mallinckrodt a royalty-bearing license to sell limited quantities of oxycodone hydrochloride extended-release tablets for a limited period of time ending in 2009; as a result, Mallinckrodt expects to begin selling oxycodone hydrochloride extended-release tablets before the end of September 2008, Covidien said.
Mallinckrodt is the sole legal source for cocaine in the United States, which it receives from a Stepan Company plant in Maywood, New Jersey, which is the only firm in the U.S. licensed to import coca leaves. Federal restrictions also bar the importation of drugs such as Esterom manufactured from cocaine, which therefore requires that they use this supplier. Mallinckrodt is also one of the U.S. importers of opium from India.

BEFORE THERE WAS A PABLO ESCOBAR THERE WAS A ANGELO MARIANI




Angelo Mariani or Ange-François Mariani (1838 - 1914) was a French chemist, originally from the island of Corsica. He is most well known as the inventor of the first cocawine, Vin Mariani in 1863. His contribution was to introduce the coca leaf indirectly to the general public. Mariani imported tons of coca leaves and used an extract from them in many products. It was Mariani's coca wine, though, that made him rich and famous. Mariani was also awarded with a medal of appreciation from the Pope. This tonic wine is deemed as the Coca Cola ancestor. Indeed the original composition of the soft drink from Atlanta is clearly inspired from the French cocawine.

BEFORE THERE WAS A NICKY BARNES THERE WAS A HEINRICH DRESER:THE OWNER OF THE BRAND
















Heroin was first synthesized in 1874 by C. R. Alder Wright, an English chemist working at St. Mary's Hospital Medical School in London, England. He had been experimenting with combining morphine with various acids. He boiled anhydrous morphine alkaloid with acetic anhydride over a stove for several hours and produced a more potent, acetylated form of morphine, now called diacetylmorphine. The compound was sent to F. M. Pierce of Owens College in Manchester for analysis, who reported the following to Wright:
Doses ... were subcutaneously injected into young dogs and rabbits ... with the following general results ... great prostration, fear, and sleepiness speedily following the administration, the eyes being sensitive, and pupils constrict, considerable salivation being produced in dogs, and slight tendency to vomiting in some cases, but no actual emesis. Respiration was at first quickened, but subsequently reduced, and the heart's action was diminished, and rendered irregular. Marked want of coordinating power over the muscular movements, and loss of power in the pelvis and hind limbs, together with a diminution of temperature in the rectum of about 4° (rectal failure).[7]
Wright's invention, however, did not lead to any further developments, and heroin only became popular after it was independently re-synthesized 23 years later by another chemist, Felix Hoffmann. Hoffmann, working at the Bayer pharmaceutical company in Elberfeld, Germany, was instructed by his supervisor Heinrich Dreser to acetylate morphine with the objective of producing codeine, a constituent of the opium poppy, similar to morphine pharmacologically but less potent and less addictive. But instead of producing codeine, the experiment produced an acetylated form of morphine that was actually 1.5-2 times more potent than morphine itself. Bayer would name the substance "heroin", probably from the word heroisch, German for heroic, because in field studies people using the medicine felt "heroic".[8]
From 1898 through to 1910 heroin was marketed as a non-addictive morphine substitute and cough suppressant. Bayer gave out free samples of Heroin to doctors. The doctors prescribed it to their patients. Heroin quickly gained widespread acceptance in the medical community unaware of its addictive qualities. Bayer was soon enthusiastically selling it in dozens of countries.
Something odd happened. The doctors began noticing an inordinate demand by their patients, who did not really seem to be in respiratory distress, for Heroin cough syrup. Bayer stopped producing and selling Heroin in 1913 and deleted mention of it in their official company history. Heroin was outlawed in 1924.
Inadvertently, Bayer may have caused more headaches than they have cured